Rebiotix Inc (a Ferring Company) Email Format
Biotechnology ResearchMinnesota, United States51-200 Employees
Rebiotix Inc is a clinical-stage biotechnology company focused on leveraging the human microbiome to treat challenging gastrointestinal diseases. As part of the Ferring Pharmaceuticals Group, it develops live microbiota–based biotherapeutics aimed at addressing conditions linked to microbiome disruption, such as bacterial vaginosis and recurrent infections. The company serves healthcare providers and patients seeking new therapeutic options for complex GI and related disorders, operating within the biotechnology research industry and collaborating with partners to advance clinical development. Based in Roseville, Minnesota, Rebiotix emphasizes its role as a microbiome-focused enterprise within a larger pharmaceutical group, and it has pursued strategic collaborations to expand its pipeline and clinical programs. Recent developments include a multi-year collaboration to develop microbiota-based therapies targeting bacterial vaginosis, reflecting ongoing efforts to broaden application of its microbiome platform.
1-888-653-2347 
support@leadiq.com 
